Outpatient Department

1. Day Treatment Unit for Chemotherapy.
2. Supportive Day Treatment for low risk fever neutropenic patients, follow up outpatients and blood transfusion.
3. Private Care Unit (PCU).
4. Take-Home Oral Medication Day Treatment Pharmacy.
5. Patient Assessment Room.
6. Patient Cannulation Room.

1. Patient assessment.
2. Patient cannulation.
3. Intravenous Chemotherapy administration.
4. Intravenous fluid administration.
5. Blood and platelets transfusion.
6. Supportive care as Antibiotics and Granulocyte Colony-Stimulating Factor.
7. Patient monitoring and follow-up.

Internal Relationships/Environmental Considerations:

• Privacy:
• Optimum visual and acoustic privacy for patients during resident daily clinical rounds and chemotherapy administration.
• Privacy is one of the most important control factors affecting sound transmission between rooms; that’s a critical design consideration.


• Environment:

Traffic in the patient administration area will be minimized, in order to reduce noise and confusion frequently experienced by patients.



• Security:
• Access to the component for patients and visitors will be through one door only.
• Adjustable beds and nightstands.
• Nurse Call system.
• Individual television.
• Patient meals as per their request.
• Well-equipped rooms offer patients the necessary supervision, and comfort through the day, without the hassle of an overnight stay.

Criteria of Admission:

• Adolescents suffering from anorexia, depression or confusion.
• Bone Tumors especially amputated patients.
• Nursing Infants.

Queuing system connecting, serving both Hematology and Solid Clinics and categorizing files acc. to Duration of Chemotherapy Infusion.

(Organizing patients’ admission at Day Treatment Chemotherapy Unit)

• Clinical daily rounds for Continuing Long Infusions Chemotherapy.
• Ordering investigations for patients coming from home to Day Treatment Units for prescheduled chemotherapy.
• Follow up lab results & clinical examine to ensure that the patient is fit for chemotherapy.
• Activating the inactive chemotherapy ordered by the primary on Power Chart Oncology.
• Modifying technical errors related to Oncology Power chart orders.
• Monitoring all patients with history of hypersensitivity to a specific chemotherapy e.g. (Asparaginase E.Coli, Carboplatin, etc.).
• Observing all patients taking chemotherapy having potency to develop hypersensitivity reactions e.g. (Rituximab, Brentuximab, Aspraginase E.Coli, ImmunoGlobins, etc.).
• Documentation of any hypersensitivity reactions or any interventions that occur during therapy.
• Prescribe Take Home Medications for patients with a newly developed complain during Day Treatment accommodation.

Clinical Pharmacy at Day Treatment Units